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The hallmark of T lymphocyte recognition is combined specificity for self
MHC molecules and nominal antigen, i.e., MHC-restricted recognition. As a
rule, cytotoxic T lymphocytes (Tc)' are restricted by class I MHC molecules (K,
D, and L molecules in the mouse) (1, 2), whereas T helper lymphocyte (Th)
recognition is restricted by class II MHC molecules (I-A and I-E molecules in the
mouse) (3, 4). Both class I and class II molecules serve as immune response gene
products regulating the magnitude ofTcell responses (3-13).
Immune regulation by MHC molecules might be an important mechanism to
explain MHC-disease associations, although solid evidence for this, especially in
HLA-disease associations, is meager.
The opportunity to study the in vivo importance of class I MHC regulation of
the Tc response to a natural pathogenic agent of high virulence came with our
previous demonstration (14) of a major difference in the capacity to generate a
Sendai virus-specific Tc response between C57BL/6 (B6; H-2b) mice and H-2Kb
mutant B6.C-H-2b"'I (bml) mice . These mice differ from each other only in
three amino acids in the H-2Kb molecule (15, 16). B6 mice are responders to
Sendai virus measured by the generation of virus-specific Tc, virus-specific Th
proliferation, and NK cell activity in vitro, and by antiviral antibody production
and virus-specific delayed type hypersensitivity (DTH) in vivo (14, 17, and this
study) . In contrast, bm l mice are Tc nonresponders against this virus, but do
not differ in any of the other immune parameters (14, 17, and this study) . These
immune parameters were also studied in thymus deficient nu/nu mice. These
mice show not only deficient Tc responses, but also deficient Th responses and
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thus deficient DTH and antibody responses, although their baseline NK activity
is increased in comparison with normal mice (14, 17 and this study).
We now report that 136, bin 1, and B6 nu/nu mice differ from each other in
susceptibility to lethal pneumonia induced by intranasal (i .n.) inoculation of
virulent Sendai virus. T cell-deficient B6 nu/nu animals were most susceptible
to the lethal effects of the virus, whereas 136 mice were most resistant. bm I mice
showed intermediate susceptibility. The difference in susceptibility between B6
and bin 1 mice is ascribed to the defective Sendai-specific Tc response in bm 1
mice. The importance of Tc was further demonstrated by the complete protec-
tion of B6 nu/nu mice (in an H-2Kb-restricted manner) against a lethal virus dose
by i .v. injection of an IL-2-dependent, Sendai-specific, and H-2K`'-restricted B6
Tc clone . Thus, in this case, an association between MHC and susceptibility to a
natural pathogenic agent of high virulence is linked to Tc nonresponsiveness on
the basis of class I MHC regulation. Apart from Tc, an important role for virus-
specific Th cells in the protection against the virus is evident from the difference
in susceptibility between bin l and B6 nu/nu mice. This conclusion was supported
by the demonstration that inoculation of I-Ab-restricted Sendai-specific Th clones
clearly prolonged the lifespan of B6 nu/nu mice and bml nu/nu mice in an I-A-
restricted manner, after challenge with a lethal dose of virus, and by the
demonstration that inoculation of these Th clones provided help to virus-specific
Tc. This study provides a unique model for the further investigation of MHC-
disease associations, and shows that antigen-specific Tc and Th cells cooperate
in in vivo protection against virus infection.
Materials and Methods
Animals.
￿
Normal C57BL/6, 129/J, B10.A(4R), B10 .A(5R), and B10 .MBR mice, and
H-2 mutant B6.C-H-26 " (bm 1) and 136.C-1-14"'
12 (bm 12) mice and C57BL/6 nu/nu mice
were bred in our laboratory under specific pathogen-free conditions. bm l nu/nu mice
were bred as described previously (17). bm12 nu/nu mice were bred by mating normal
bm 12 with C57BL/6 nu/nu mice. The F, mice were mated and the F2 nu/nu mice were
H-2 typed by cytofluorographic analysis on LPS-induced (30 wg/ml), 4-d-cultured lym-
phoblasts obtained from lymph node cells. For typing, we used mAb 34-5-3S, a gift from
Dr. D . H. Sachs (National Institutesof Health, Bethesda, MD), which reacts strongly with
the lymphocytes of I-A' but not of I-Ab"' '2 mice (18). The mouse strains used in this study,
their H-2 haplotypes, and the structural alterations in the H-2 molecules of the mutant
mouse strains are listed in Table I . All mice were used at 6-12 wk of age.
Viruses.
￿
Nonvirulent Sendai virus, lot 40340087, was obtained from Flow Laboratories
(McLean, VA) . This virus had been propagated in pathogen-free eggs. The titer was 104
hemagglutinating units (HAU) per milliliter. Virulent Sendai virus, strain P3193, was a
gift of Dr. J. C. Parker (Microbiological Associates, Bethesda, MD). This virus was
propagated in the lungs of 129/J trice. Homogenates of infected lungs (10% suspension,
wt/vol, in basal [Eagle's] medium with antibiotics, clarified at 2,300 g for 20 min at 4°C)
were inoculated by i.n. instillation of 0.02 in] of 10% suspension of infected mouse lung
cells . Lungs of mice were harvested 6 d after inoculation. P3193 virus was tested by the
mouse antibody-production test (20), and found not to contain other murine virus
contaminants. The titer was 3 .2 x 105 50% tissue culture infective dose (TCID5o) per
milliliter. Both viruses were stored at -70°C.
Virus Titration and Quantitation. Virus titration and quantitation were performed
essentially as described (21) with slight modification . For virus titration in tissue culture,
clarified 10% suspensions of infected lung cells were diluted 10-fold, and 0 .1 in] was
inoculated into each of four 2-ml wells of a 24-wells plate (Nunc, Roskilde, Denmark)H-2
Mouse strain
￿
Abbreviation
￿
-
￿
Structural alteration
C57BL/6 B6 b b b
C57BL/6 nu/nu
￿
B6 nu/nu
￿
b
￿
b
￿
b
129/J
￿
129/J b b b
B10.A(4R) 4R k k b
B10.A(5R) 5R b b d
B10.MBR MBR b k q
B6.C-H-2b"''
￿
bm 1
￿
bm l
￿
b
￿
b position 152*
Arg--~ Tyr at position 15511
Leu -~ Tyr at position 156¢
B6.C-H-2b",' nu/nu
￿
bmI nu/nu
￿
bml
￿
b
￿
b
￿
Same as bmI
B6.C-H-2b",32" ￿bm 12
￿
b
￿
bm 12
￿
b
￿
Ile -i- Phe at position 671
Arg -~ Giu at position 701
Thr
￿
Lys at position 71 1
Same as bin12 B6.C-H-2''2 nu/nu
￿
bm12 nu/nu
* Congenic or coisogenic with C57
$ According to Pease et al. (15)
According to Nairn et al. (15)
1 According to McIntyre et al. (19)
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containing a monolayer of primary rhesus monkey kidney cells (a gift from Dr. M. Jonker,
TNO, Rijswijk, The Netherlands). Cells were observed for cytopathic effects daily for 14
d, and end-point titers were calculated by the methods of K5rber (22). Virus titration and
quantitation in vivo was done using four mice from each of the strains B6, bm1, or B6
nu/nu at each titration point. They were inoculated i.n., each with 0.02 ml of a 3 .33-fold
virus dilution. The same person (W. M. Kast) made all inoculations throughout the
. Infected mice were observed for disease and death up to day 28 or
During these experiments, mice were housed in an isolator in which the airflow
s directed from cages containing mice infected with low doses of virus to cages with
mice infected with high doses of virus to avoid contamination. Virus titers are expressed
as the number of TCID5o per 0.02 ml required to cause a lethal infection (LD5o).
Immunizations and Elicitation of DTH.
￿
Sendai virus-specific DTH responses were
elicited in the ear. Mice were primed with 102 HAU noninfectious Sendai virus 6 d before
challenge by i.n. instillation of 20 Ecl of Sendai virus suspension diluted in PBS. The
challenge was given by injectiof into the dorsal surface of the ear a total volume of 25'I
of either PBS (right ear) or 10
￿
HAU Sendai virus diluted in PBS (left ear) using a 50 Al
Hamilton syringe fitted with a 30-gauge needle. The same procedure was performed in
nonimmunized (naive) control nice. Ear swelling was measured with a Mitutoyo model
102-217 micrometer (Steenkist-Rooymans, Eindhoven, The Netherlands). The percent-
age increase in ear swelling was calculated as [(thickness of left ear) - (thickness of right
ear))/(thickness of right ear). In another type of experiment, naive mice from various
strains were injected in both ears with 2 X 105 cells of a particular T cell clone. Either
PBS (right ear) or 102 HAU Sendai virus in PBS (left ear) was included in the injection
mixture in a total volume of 25 Ad.
T Cell Clones.
￿
Culture conditions for generation of T cell clones were essentially the
same as described before (14). In brief, C57BL/6 and bml mice were injected i.p. with
102 HAU Sendai virus. 3 wk later, spleen cells of these mice were restimulated in vitro
with syngeneic, Sendai virus-coated, irradiated (2,500 rad) spleen cells (stimulator cells)
for 5 d. Culture medium consisted of Iscove's modified Dulbecco's medium (IMDM)
(Gibco, Grand Island, NY), supplemented with 10% pooled human serum, penicillin (100
IU/ml), streptomycin (100 Pg/ml), and 2-ME (2 X 10-5 M). Effector cells were726
density gradient (lympholyte M ; Cedarlane Laboratories, Hornby, Canada), and cultured
again in the same way. This procedure was repeated three times, after which a precursor
frequency was established in a limiting-dilution assay, using 96 U-shaped well plates
(Titertek; Flow Laboratories, McLean, VA) with 1 .5 X 105 Sendai-coated syngeneic
stimulator cells and 12.5% rat cell supernatant (RF) as lymphokine source (17) in a total
volume of 200,u] culture medium. Wells that showed cell growth at a dilution below 10%
ofthe precursor frequency were transferred into 24-mm Costar wells (Costar, Cambridge,
MA). Cells were routinely subcultured once a week. Th clone 6C3, derived from a B6
mouse, and Th clone I H 11, derived from a bm 1 mouse, both have the marker profile
Thy-I +, L3T4+, Lyt 2-, and produce IL-2 and IFN-y after Con A stimulation (not shown).
Tc clone 5, derived from a B6 mouse, has the marker profile Thv-1+, L3T4-, Lyt 2+.
This clone produced IFN-y, but did not produce IL-2 after Con A stimulation (not
shown). They were tested in in vivo and in vitro assays ^-2 mo after establishment. Th
clone EA-7, specific for egg albumin and derived from a B6 mouse, was originally
described by Dr. M. H. Schreier (23), and was obtained through the kind courtesy of Dr.
R. Benner and I . S. Klasen (Erasmus University, Rotterdam, The Netherlands).
To explore the protective capabilities of these clones, naive mice were inoculated i.n.
with 10 LD50 Sendai virus, and 1 It later were given one i .v. injection of cloned T cells in
PBS or PBS alone. The results of these tests are given in mean survival time ±SD. For
statistical analysis of these results, the Mann-Whitney U test was used.
Recombinant IL-2.
￿
Recombinant IL-2 (batch RNB 85738/09Y) was obtained from
Biogen (Geneva, Switzerland). In protection experiments, it was administered as a single
subcutaneous injection of 1 .25 X 104 U/mouse in CFA, with 0.5% BSA.
Proliferative Response of Sendai-specific Th Clones.
￿
Th cell clones (104) were cultured
with 5 X 105 Sendai-modifiedor nonmodified spleen cells that were irradiated with 2,500
rad in flat-bottomed tissue culture plates (Costar) in a total volume of 0 .2 ml culture
medium containing 12.5% RF. Cultures were incubated at 37°C and 5% C02 for 4 d,
the last 4 h in the presence of 0 .4 yCi [5H]thymidine added in 20 j1. The cells were
harvested with an automated cell harvester, and radioactivity was measured in a liquid
scintillation counter. The data presented constitute the mean value of five replicate wells
(in cpm).
NK Cell Assay.
￿
Varying numbers of spleen cells of different mouse strains were used
as effector cells at different times after i.p. inoculation with 3 X 102 HAU Sendai virus
against 5 X 105 Na"Cr-labelled YAC-1 target cells in 0.2 ml culture medium in wells of
roundbottomed microtiter plates. After 6 h incubation at 37'C in humidified air with 5%
C02 the percent specific 'Cr release was determined as described (14). Background
release was always <15%. The standard error of triplicate cultures was always <3%
specific "Cr release.
Measurement of Te E .'ffector Activity.
￿
Tc effector activitZ of Te clone 5 (Tc-5) was
essentially measured as described (14). As targets, we used ''Cr-labelled Con A-induced
(2 .5 jug/ml) lymphoblasts (3-d cultures). Percent specific "Cr release was determined as
described (14). Background release was always <25% . The standard error of triplicate
cultures was always <3% specific "Cr release.
DAI VIRUS PNEUMONIA
Results
Sendai Virus-specific DTH Response
Primed 136, bm l , and B6 nu/nu as well as unprimed (naive) B6 mice were
tested for their ability to generate a Sendai virus-specific DTH response . As
shown in Fig. 1, unprimed B6 mice could not generate a Sendai virus-specific
DTH response. Primed B6 and bm I mice showed equal percentages of ear
swelling after challenge with Sendai virus. Thus, these two mouse strains did not
differ in the DTH response to Sendai virus . In contrast, B6 nu/nu mice could
not generate a Sendai-specific DTH response, illustrating the T cell dependency
of the DTH response.NK Cell Activity
N
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0
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FIGURE 1 . Sendai virus-specific DTH response . Mice were naive (not primed) or were
primed with 102HAU Flow Sendai virus 6 d before challenge by i .n . instillation of 20 Al of
virus suspension diluted in PBS . The challenge was given by injection of a total volume of 25
juI ofeither PBS (right ear) or 10 2 HAU Flow Sendai virus diluted in PBS (left ear) . The same
procedure was performed in nonimmunized (naive) control mice . Ear swelling was measured
at 24 (white bar), 48 (shaded bar), or 72 h (black bar). Data are expressed as the mean
percentage ± SE of 100 X [(left ear thickness) - (right ear thickness)]/(right ear thickness) for
groups of 35 B6, 12 bm1, 17 B6 nu/nu, and 6 B6 naive mice .
0 2 4 6 6 10 100
days after virus inoculation
FIGURE 2 .
￿
Time course of NK activity in spleen cells of different mouse strains after i.p .
inoculation with 3 X 102HAU Sendai virus per mouse . Symbols represent NK activity of : A,
bml mice ; ", B6 mice; ", B6 nu/nu mice . Cytotoxic activity was measured by "Cr release
assay using "Cr-labelled YAC-1 cells as targets .E/T ratio was 100:1 . Each data point represents
the mean ± SEM of six mice .
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The time course of NK cell activity was studied in naive B6, bml, and B6
nu/nu mice after 3 X 102 HAU Sendai virus inoculation per mouse (Fig . 2) . NK
cell activity in control mice was 31 ± 2% specific "Cr release at an E/T ratio of
100 :1 for B6 mice ; 26 ± 2% for bm 1 mice, and 50 ± 8% for B6 nu/nu mice
(mean ±SEM of six mice) . The initial elevation in NK cell cytotoxic activity was
observed 1 d after infection . Peak levels of NK activity occurred on the second
day, and by the eighth day, it had declined to normal levels . B6 and bml mice
showed equal kinetics of NK cell activity before and after priming with Sendai
virus . In contrast, B6 nu/nu mice, though displaying the same time course of728
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TABLE II
Susceptibility ofDifferent Mouse Strains to
Virulent Sendai Virus Infection
* Different groups of naive mice were titrated by i.n. inoculation of 0.02
ml of 3 .33-fold virus dilutions.
$ Onetitration consisted of at least seven titration points. Four mice were
used at each titration point.
Values of the mean LD50 ± SD expressed in tissue culture infective
dose5o per 0.02 ml.
NK cell activity, showed a higher basic level of NK activity, with a return to
similar values after infection. Thus B6 and bml mice did not differ in NK cell
activity and NK cell activity kinetics after challenge with Sendai virus, whereas
B6 nu/nu mice had high baseline NK cell activity before and after challenge with
Sendai virus.
Susceptibility to Virulent Sendai Virus Infection
C57BI./6 (B6), H-2K' mutant bmI, and 136 nude (nu/nu) mice were challenged
i.n. with virulent Sendai virus to study their susceptibility (Table II). We found
that the LD50 for the Sendai Tc-deficient bml strain was ^-10 times lower than
for the B6 strain, compatible with an important role of virus-specific Tc. The
LD50 for the T cell-deficient B6 nu/nu strain, in turn, was 30 times lower than
for the bm1 strain, indicating an important role of T cells other than Tc, notably
Th cells, in antiviral immunity. To further confirm the notion that both Th and
Tc cells are important in antiviral immunity, nude mouseprotection experiments
with Th and Tc clones were carried out.
Characterization ofSendai Virus-specific Th and Tc Clones
Sendai virus-specific Th clones are class II (I-A)-restricted.
￿
The capacity of Th-
6C3 and -1H 1 I to proliferate in a Sendai virus-specific manner was tested
against Sendai-coated stimulator cells of various H-2 types. Table III illustrates
that both clones specifically proliferate to Sendai virus, but only against I-A-type
stimulator cells. Non-I-Ab 1310 MBR-, and bm l2 (I-Ab mutant) Sendai-coated
stimulator cells were nevertheless able to stimulate an H-2Kb-restricted Sendai-
specific Tc line (not shown), thereby excluding the possibility that these cells
failed to express Sendai virus antigens . Thus, Th-6C3 and -11-111 are I-Ab-
restricted.
Sendai virus-specific DTH responses mediated by Th clones are also class II (I-A)-
restricted. The ability ofTh-6C3 to function in vivo was shown by the induction
of a Sendai-specific DTH response. Fig. 3 shows that Th-6C3 is capable of
inducing a DTH response to Sendai virus only when the host has MHC deter-
minants of the I-At' type. The possibility that the presence of allodeterminants
on either the T cell clone or the host suppressed a potential response in I-Ab-
disparate MBR, 4R mice and bm12 was ruled out, because 5R mice also have
Mouse strain* Number of replicate
titrations$ LD50 ± SD§
C57BL/6 4 152.0 ± 74.9
B6.C-H-26"'' 3 14.7 ± 4.8
C57BL/6 nu/nu 2 0.5 ± 0.6141
1.1
Z1
111
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FIGURE 3 .
￿
DTH response elicited by Th clone 6C3 . Th clone cells (2 X 10 5 ) were injected
into both ears of naive mice of the strains indicated . Naive mice by themselves cannot generate
a DTH response to Sendai virus (Fig . 1) . Either PBS (right ear) or 10 2 HAU flow Sendai virus
in PBS (left ear) was included in the injection mixture in a total volume of 25 PI . Ear swelling
was measured at 24 (white bar), 48 (shaded bar), or 72 h (black bar) . Data are expressed as
the mean percentage ± SE of 100 x [(left ear thickness) - (right ear thickness)]/(right ear
thickness) for groups of five mice .
Clone
TABLE IV
Sendai Virus-specific and Kb-restricted Killing Activity of Tc Clone 5
Percent specific "Cr release using target cells at E/T ratios of 5:1
B6S (bbb)$
￿
B6
￿
bm1S (bmlbb)
￿
bml
￿
4RS (kkb)g
￿
4R
￿
5RS (bbd)
￿
5R
56 0
￿
4
￿
7
￿
1 2 51 0
* Mean of triplicate determinations . 104Con A blasts used .
S, Sendai virus-infected .
4R Sendai virus-infected cells are always killed by syngeneic anti-Sendai effector cells (not shown) .
multiple H-2 differences from the B6-derived T cell clone . These data show that
the in vivo restriction specificity of this Th clone is also I-Ab encoded . Similar
results were obtained with the bm 1 Th-1H I I (not shown) .
Sendai virus-specific Tc clone is class I (Kb)-restricted.
￿
The capacity of Tc-5 to
generate Sendai-specific lytic activity was demonstrated against Sendai-infected
target cells of various H-2 types . Table IV shows that Tc-5 specifically killed
Sendal-infected targets only when they expressed the Kb molecule . This Tc clone
was further characterized by the ability to induce a Sendai-specific DTH re-
sponse, and by its ability to proliferate in vitro in a Sendai-specific manner only
against Kb-type stimulator cells (not shown) . These data show that the restriction
specificity of Tc-5 is Kb .
Protection Against Lethal Sendai Virus Infection in nu/nu Mice by T
Cell Clones
In three separate experiments (shown in Tables V, VI, and VII), wedetermined
whether these clones could protect against a lethal Sendai virus infection .
Therefore, B6 nu/nu, bmI nu/nu, and bm12 nu/nu mice were given a Sendai
virus dose of 10 LD5 i .n ., and simultaneously, T cell clones or PBS i.v . TablesKAST ET AL.
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TABLE V
Protection against Lethal Sendai Infection in Different Mouse Strains by Th Clones (Exp. 1)
* Different groups of naive mice were inoculated i.n. with 10 LDSO Sendai virus and 1 h later were
given one injection i.v. with T cell clones, diluted in PBS, or only PBS. Th-6C3 is a Sendai virus-
specific B6 Th clone. Th-1HI 1 is a Sendai virus-specific bin1 Th clone.
$ Mann-Whitney U test vs. mice injected with PBS.
TABLE VI
Protection against Lethal Sendai Virus Infection in Different Mouse Strains by
Th and Tc Clones (Exp. 2)
Mouse
strain
B6 nu/nu
bin12 nu/nu
Where indicated, mice were also injected s.c. with 1.25 X 10' U rIL-2. Tc-5 is a Sendai virus-
specific B6 Tc clone, and Th-EA-7 is an egg albumin-specific B6 Th clone.
* As in Table IV.
~ Mann-Whitney U test vs. B6 nu/nu mice injected with PBS.
V, VI, and VII show that B6 nu/nu mice die between days 15 and 19. Injection
of B6 Th-6C3 extended the survival time of B6 nu/nu mice by a factor of two
(Tables VI and VII) or three (Table V). This effect was dose dependent (Table
VI). Although life prolongation was reached with Sendai-specific Th clones in
all three experiments, no permanent survivors were observed. The I-Ab restric-
Mousestrain Number of
mice tested
Cells injected
(number of cells)*
Survival time
(mean ± SD)
d
Signifi-
cance
(p)*
Range
d
B6 nu/nu 24 PBS 19.6 ± 5.4 11-28
3 Th-6C3 (107) 57.3 ± 6.4 <0.001 50-62
bm12 nu/nu 6 PBS 21 .3 ± 5.5 14-27
3 Th-6C3 (10') 18.6 ± 3.2 >0.1 15-21
bml nu/nu 6 PBS 15.5 ±3 .0 11-20
3 Th-1 H1 1 (10') 48.3 ± 9.0 0.012 39-57
B6 +/+ 20 PBS 8.0 ± 1.4 6-12 >0.1
bml +/+ 20 PBS 8.1 ± 2.1 6-14 >0.1
Number of
mice tested
Cellsinjected
(numberof cells)*
Survival time
(mean ± SD)
d
Significance
(p)$
Range
d
6 PBS 18.8 ± 5.0 13-25
3 Th-6C3 (107) 35.7 ± 4.9 0.012 30-39
3 Th-6C3 (3 x 106) 33.7 ± 3.8 0.012 31-38
3 Th-6C3 (106) 25.3 t 10.8 >0.1 13-33
3 Tc-5 (3 x 106) 25.0 ± 1.0 0.024 24-26
3 Tc-5 (3 x 106) + Th-6C3 >100.0 0.012 -
(3 X 106)
3 Tc-5 (3 X 106) + rIL-2 >100.0 0.012 -
4 Th-EA-7 (10') + rIL-2 21 .2 ± 3.8 >0 .1 16-25
4 Th-6C3 (107) 20.1 ± 5.3 >0.1 13-25732 MHC-LINKED SUSCEPTIBILITY TO SENDAI VIRUS PNEUMONIA
TABLE VII
Protection against Lethal Sendai Virus Infection in DifferentMouse Strains by
Th and Tc Clones (Exp. 3)
* As in Table V.
$ Mann-Whitney U test vs. B6 nu/nu mice injected with PBS.
§One mouse died on day 26, the other three remained healthy beyond day 50.
TABLE VIII
Summary ofImmune Responses against Sendai Virus in
DifferentMouse Strains
Assay of immune response
In vitro
Tc
T cell proliferation
NK
In vivo
Antibody production
DTH
Resistance against infection
Mouse strain
Reference
B6
￿
bm 1
￿
B6 nu/nu
-
￿
14, 17
-
￿
14, 17
++
￿
This study
14, 17
This study
This study
tion specificity of Th-6C3 was again apparent in vivo, because bm 12 nu/nu mice
could not be protected from death by this clone (Tables V and VI). Analogous
injection of bm i Th-1 H11 into bm 1 nu/nu mice could also significantly extend
their survival time (Table V). Injection, however, of an I-A'-restricted B6 Th
clone specific for egg albumin had no protective effect (Table VI), illustrating
that the life prolongation by the Sendai-specific Th clones was specific. The
mean survival time of normal B6 and bm 1 mice could not be extended by i.v.
injection with Th-6C3 or -1 H11, respectively (Table V), probably because the
LDS0 virus dose for T cell-competent animals is so much higher that much
higher doses of cloned T cells would be required for measurable protection. The
Sendai virus-specific B6 Tc-5 by itself only marginally butsignificantly extended
the survival time of B6 nu/nu mice (Tables VI and VII). However, upon injection
of a combination of 3 X 106 Tc-5 and 3 X 106 Th-6C3 cloned T cells, almost all
mice survived and remained healthy (Tables VI and VII), indicating cooperation
between Th and Tc cells in antiviral immunity. Probably Th cells mediate their
activity in this cell-cell cooperation at least partially by IL-2 release, because
Mouse
strain
Number of
mice tested Cellsinjected (number of cells)* Survival
(mean ±
d
time
SD)
Significance
(p)
Range
d
B6 nu/nu 8 PBS 15 .5 ± 2.6 13-20
4 Th-6C3 (3 x 106) 30 .3 ± 7.6 0.002 21-37
4 Tc-5 (3 x 106) 23.5 ± 1.7 0.002 22-25
4 Th-6C3 (3 X 106) + Tc-5 (3 X 106) >50.0§ 0.002 -
4 Th-6C3 (3 X 106) + Tc-5 (106) 31 .5 ± 9.0 0.002 21-39
4 rIL-2 16.7 ± 2.4 >0.1 15-20
bmI nu/nu 4 Tc-5 (3 X 106) + rIL-2 13.7 ± 2.9 >0.1 12-18KAST ET AL.
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permanent survival was also achieved by injection of a mixture of 3 x 106 Tc-5
and IL-2 (Table VI). rIL-2, by itself (Table VII) or in conjunction with an
irrelevant Th clone (Table VI), had no protective effect. The protective effect
of Tc-5 under conditions of sufficient Th supply was dose dependent (Table
VII), and the in vitro H-2Kb restriction specificity of Tc-5 was also apparent in
vivo because bm 1 nu/nu mice could not be protected from death by this clone
(Table VII) under conditions where B6 nu/nu mice could be protected (Table
VI).
Discussion
This study establishes a clear association between MHC type and susceptibility
to Sendai virus-induced lethal pneumonia. Mutation of three amino acids in the
H-2Kb class I molecule in bm l mice causes a higher susceptibility to the lethal
effect of the virus, compared with B6, the strain of origin. The only measurable
difference in Sendai-specific immune responses between bml and B6 mice is the
inability of the mutant to generate Sendai-specific Tc (Table VIII). This differ-
ence is also the only expected difference, because class I MHC molecules only
restrict and regulate Tc responses, and because no other genetic differences
between B6 and bm 1 mice are known to exist. Indeed, all other immune
responses, such as DTH (Fig. 1), T cell proliferation (Table VIII), and antibody
production (Table VIII), as well as NK activity (Fig. 2) of these two mouse strains
were identical. The likelihood that the increased virus susceptibility and the Tc
nonresponsiveness of the bm l mouse are causally related is further enhanced by
the fact that the H-2Kb molecule is the only functional class I MHC restricting
element for Sendai virus-specific Tc in B6 mice (14).
The importance of virus-specific Tc in antiviral immunity was further revealed
by the fact that B6 nu/nu mice could be protected from death by transfer of a
B6 Sendai virus-specific Tc clone. A positive control for the importance of Tc
against Sendai virus in bm I mice would be a transfer of bm 1 Sendai-specific Tc
clones into lethally infected bm 1 mice. However, bm 1 mice are Tc nonresponders
against Sendai virus, therefore, such bm l Sendai-specific Tc clones are non-
existent, even after prolonged cell culture in vitro with IL-2 (W. M. Kast,
unpublished observations). Moreover, transfer of B6 Tc clones specific for Sendai
virus into lethally infected bm l mice is unlikely to have any protective effect
because of the MHC restriction of these Tc clones in vitro (Table IV) and in
vivo (Table VII) .
One of the most striking features of antiviral T cell immunity revealed here is
the cooperation between Th and Tc cells in antiviral immunity. Permanent
survival of lethally infected nu/nu mice was achieved only with a mixture of
virus-specific Th and Tc (Tables VI and VII) or a mixture of Tc and rIL-2
(Table VI). The cooperative effect of Th cells can at least partially be explained
by the release of IL-2, because (a) Th-6C3 and -IHI I produce IL-2, whereas
the Tc-5 does not (data not shown), and (b) the Th cell in this cell-cell cooperation
can be replaced by rIL-2 (Table VI). This type of T-T cooperation is reminiscent
of Th/Tc cooperation in the T cell response to MHC alloantigens (24-26) and
the male antigen, H-Y (27). IL-2 release does not explain the fact, however, that
Th clones by themselves, without Tc, also display a marked protective effect734
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(Tables V-VII), because rIL-2 by itself (Table VII) or in conjunction with an
irrelevant Th clone (Table VI) has no protective effect .
The importance of Th cells was further revealed by the difference in suscep-
tibility (to Sendai virus infection) between T cell-deficient B6 nu/nu mice and
Tc-deficient bml mice (Tables II and VIII). It seems likely that this difference
is due (directly or indirectly) to the generation ofSendai-specific Th cells in bm1
mice .
Transfer of immune T cells was shown (28-30) to protect against several
viruses such as influenza virus, herpes simplex virus type 1 (31), and lymphocytic
choriomeningitis virus (LCMV) (32, 33). Usually, Tc clones were transferred in
the same, or even higher amounts than in this study. When Th cells were used,
they sometimes worsen (34) or ameliorate (35) virus-induced disease. In our
system, the protection by Th and Tc clones against lethal infection could be
titrated (Tables VI and VII). Also, as expected from the results of DTH
experiments indicating I-A' restriction in vivo, the Th clones could not protect
I-A''-disparate bm12 nu/nu mice from death (Tables V and VI). Furthermore
the Tc clone could not protect H-2Kb-disparate bml nu/nu mice from death
(Table VII). In vivo protection with immune T cells against virus infection only
functions in syngeneic situations (31, 32). In these studies, completely different
allogeneic strains were used, so that the exact genetic restriction element was
not identified. We now show that the in vivo protection by cloned Th cells shows
the same I-A' restriction as in vitro proliferation and in vivo DTH reaction, and
that the in vivo protection by cloned Tc cells shows the same H-2K`' restriction
as in vitro cell-mediated cytotoxicity.
The exact mechanism(s) by which both Th and Tc clones exert their protection
remain(s) to be solved, but (Table V [Exp. 1]) no Sendai-specific Tc or Sendai-
specific antibody production was demonstrable in nu/nu mice 42 dafter injection
ofthe Th clones alone, whereas at 40 d after Th clone transfer, these mice were
still capable of generating Sendai-specific DTH reactions (data not shown). One
possible protective mechanism of Th and Tc is production of IFN-y, which is
released by both our Th and Tc clones (data not shown). In experiments with
influenza virus (29)and with herpes virus (31), only those Tc clones that produced
IFN-y could clear the virus in vivo. However, recent experiments (30), also in
the influenza system, showed that the protective effect ofcloned Tc was highly
specific and probably not correlated with IFN-y production. Therefore the
straightforward possibility that Tc protect by killing virus-infected cells remains
a distinct one, and is currently our favorite.
A direct link between MHC type and susceptibility to acute viral illness has
not been established before. On the other hand, the association between MHC
type and susceptibility to chronic disease induction by RNA tumor viruses, where
immune mechanisms are probably responsible for protection, is well established
(36-42). In this case, again, the ability to generate a strong MHC-regulated
immune response is associated with resistance to the induction of disease. In
lethal LCMV-induced choriomeningitis, however, the generation of a strong
MHC-regulated immune response (notably class I-restricted Tc) is associated
with susceptibility to the induction ofdisease. In this model (e.g., intracerebral
inoculation of LCM virus), the autoaggressive potential of the antiviral immuneresponse outweighs the beneficial effects of the IT cell response (43-46). Indeed,
recently (47), Zinkernagel et a] . showed that mice producing Tc against LCMV
because they have an appropriate H-21)-restricting element die after infection,
whereasmice that do not generate Tc because they lack aproper H-21)-restricting
element survive (47). Thus, generation of a strong class I MHC-regulated
antiviral Tc response can have two final results: increased resistance to the
induction of disease, as demonstrated in this study, or increased susceptibility to
the induction of disease (e.g., LCMV) (47). The outcome depends on a series of
factors, including cytopathogenicity and virulence of thevirus, and thebeneficial
versus harmful effects of T cell activity (48).
Summary
The in vivo importance of class I MHC regulation of the Tc response to a
natural pathogenic agent of high virulence was studied on the basis of our
previous demonstration ofa majordifference in the capacity to generate aSendai
virus-specific ,rc response between C57BL/6 (116, FV2
b
) nice and 1-120 mutant
B6.C-H-2b I (bm 1) mice . These two mouse strains differ from each other only
ee amino acids in the crucial FI-2EK
b restriction element for this response.
bmI mice, in contrast to B6 mice, are Tc nonresponders against this virus, but
show Sendai-specific T cell proliferation, antibody production, and DTH reac-
tions, as well as NK cell activity, equal to those of B6 mice.
B6, Sendai Tc-deficient bmI and T cell-deficient B6 nu/nu mice differ from
each other in susceptibility to lethal pneumonia induced by i.n. inoculation of
virulent Sendai virus. The lethal dose (LD50) in B6 mice averaged 152 TCID50,
in bm I mice, 14 TCID50 and in B6 nu/nu mice 0.5 TClInv The importance of
Tc was also shown by thecomplete protection of B6 nu/nu mice against infection
with a lethal virus dose by i.v. injection ofa Sendai virus-specific, IL-2-dependent
and H-2K
b-restricted B6 Tc clone. In vivo protection by this Tc clone was H-
2K'-restricted.
Apart from Tc, an important role for virus-specific Th cells is evident from
the difference in susceptibility between bm I and B6 nu/nu mice. This conclusion
was supported by the demonstration that the mean survival time of B6 nu/nu
and bml nu/nu mice could be significantly prolonged, in an I-A
b-restricted
manner, by the injection of in vitro-propagated, Sendai-specific B6 or bm,I Th
clones after a lethal dose of Sendai virus, and by the demonstration that
inoculation of these Th clones provided help to virus-specific Tc by means of
IL-2 production. Strikingly, Th and Tc cooperate in anti-Sendai virus immunity,
ce permanent survival of lethally infected nu/nu mice was only achieved by
inoculation of a mixture of Tc and Th clones or a mixture of a Tc clone and
rl L-2.
This study provides a unique model forthe studyof MHC-disease associations.
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